Company Profile

Mycrodose Therapeutics

San Diego-based pharmaceutical company developing advanced drug-delivery systems (transdermal, oral, implant and capsule) for sustained microdosing of psychedelic compounds to treat mental-health and cognitive conditions. It holds a DEA Schedule I license to research psilocybin, LSD, MDMA and DMT.

Mycrodose Therapeutics News 2 articles